摘要
目的:分析和探讨重组人干扰素α-1b联合消旋卡多曲治疗婴幼儿病毒性腹泻临床效果.方法:选取我院2013-01/2014-01收治的110例婴幼儿病毒性腹泻患者,通过随机数字表法分为对照组(n=55)和观察组(n=55),对照组患儿采用消旋卡多曲治疗,观察组患儿采用重组人干扰素α-1b联合消旋卡多曲治疗,对两组患儿临床治疗效果作比较分析.结果:观察组患儿临床治疗有效率显著高于对照组,住院时间较对照组患儿更低(P<0.05).结论:在婴幼儿病毒性腹泻治疗中,采用消旋卡多曲与重组人干扰素α-1b联合治疗,能明显改善临床症状,缩短住院时间,减轻患儿痛苦,疗效显著,值得临床推广应用.
AIM： To analyze and discuss the clinical effect of recombinant human interferon alpha 1 b combined with racecadotril in the treatment of infantile viral diarrhea. METHODS： A total of 110 infantile viral diarrhea patients admitted into our hospital from January 2013 to January 2014, were randomly divided into control group （ n = 55 ） and observation group （ n = 55 ） according to a random number table method. Control group were received racecadotril, while observation group were given recombinant hu- man interferon alpha-lb combined with racecadotril, and the clin- ical therapeutic effect of two groups were compared. RESULTS ： Observation group with clinical effective rate of the treatment was significantly higher than that of the control group, and the hospi- talization time was less than the control group （ P 〈 0.05 ）. CON- CLUSION： The clinical effects of recombinant human interferon alpha 1 b combined with racecadotril in the treatment of infantile viral diarrhea can significantly improve the clinical symptoms, shorten the time of hospitalization and relief the pain of patients, which is safe and effective and worth of clinical promotion.
出处
《转化医学电子杂志》
2015年第6期105-106,共2页
E-Journal of Translational Medicine
